TY - JOUR
T1 - Phytochemicals and their possible mechanisms in managing covid‐19 and diabetes
AU - Sandoval‐gallegos, Eli Mireya
AU - Ramírez‐moreno, Esther
AU - Vargas‐mendoza, Nancy
AU - Arias‐rico, José
AU - Estrada‐luna, Diego
AU - Cuevas‐cancino, José Javier
AU - Jiménez‐sánchez, Reyna Cristina
AU - Flores‐chávez, Olga Rocío
AU - Baltazar‐téllez, Rosa María
AU - Morales‐gonzález, José A.
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/9
Y1 - 2021/9
N2 - For the writing of this manuscript, we searched information published from 2000 to 2021, through PubMed, Web of Science, Springer, and Science Direct. Focusing on the effects related to respiratory diseases, in addition to possible direct effects towards SARS‐CoV‐2, coupled with dia-betes. Diabetes is a metabolic disease that is characterized by affecting the function of glucose, in addition to insulin insufficiency. This leads to patients with such pathologies as being at greater risk for developing multiple complications and increase exposure to viruses infections. This is the case of severe acute respiratory disease coronavirus 19 (SARS‐CoV‐2), which gave rise to coronavirus disease 2019 (COVID‐19), declared an international public health emergency in March of 2020 Cur-rently, several strategies have been applied in order to prevent the majority of the consequences of COVID‐19, especially in patients with chronic diseases such as diabetes. Among the possible treatment options, we found that the use of phytochemical compounds has exhibited beneficial effects for the prevention and inhibition of infection by SARS‐CoV‐2, as well as for the improvement of the manifestations of diabetes.
AB - For the writing of this manuscript, we searched information published from 2000 to 2021, through PubMed, Web of Science, Springer, and Science Direct. Focusing on the effects related to respiratory diseases, in addition to possible direct effects towards SARS‐CoV‐2, coupled with dia-betes. Diabetes is a metabolic disease that is characterized by affecting the function of glucose, in addition to insulin insufficiency. This leads to patients with such pathologies as being at greater risk for developing multiple complications and increase exposure to viruses infections. This is the case of severe acute respiratory disease coronavirus 19 (SARS‐CoV‐2), which gave rise to coronavirus disease 2019 (COVID‐19), declared an international public health emergency in March of 2020 Cur-rently, several strategies have been applied in order to prevent the majority of the consequences of COVID‐19, especially in patients with chronic diseases such as diabetes. Among the possible treatment options, we found that the use of phytochemical compounds has exhibited beneficial effects for the prevention and inhibition of infection by SARS‐CoV‐2, as well as for the improvement of the manifestations of diabetes.
KW - COVID‐19
KW - Curcumin
KW - Diabetes
KW - SARS‐CoV‐2
KW - Silymarin
KW - Sulforaphane
UR - http://www.scopus.com/inward/record.url?scp=85114320240&partnerID=8YFLogxK
U2 - 10.3390/app11178163
DO - 10.3390/app11178163
M3 - Artículo de revisión
AN - SCOPUS:85114320240
SN - 2076-3417
VL - 11
JO - Applied Sciences (Switzerland)
JF - Applied Sciences (Switzerland)
IS - 17
M1 - 8163
ER -
